COZING-WS11

COZING-WS11/WS11H Advantages:

Type-C charging port (compatible with mobile charging cables).
Ear and nose applicators can be used together or separately.
Professional treatment protocols included.
CE-certified with positive clinical trial results.
Real-time treatment monitoring via display.
Easy to use

Inquire Now Next Product

Product Overview

Treatment Principle

The laser therapy watch helps manage diabetes by improving blood glucose levels. Blood sugar (glucose) is the body's primary energy source, but excessively high levels can impair insulin secretion from β-cells, leading to diabetes—a chronic condition.

In China, 3%–5% of the population (over 50 million people) has diabetes, with 90% being Type 2 diabetics.

The semiconductor laser treatment device has shown 96% effectiveness in managing diabetes. It is particularly beneficial for complications like:

Peripheral neuritis

Diabetic nephropathy

Retinal fundus disease

Skin ulcers

Compared to drug therapy, laser irradiation provides superior results by:

Reducing oxidative stress

Improving blood rheology and microcirculation

Preventing diabetic microangiopathy

For diabetes treatment protocols, please contact us.

COZING-WS11

Technical Parameters:

Feature	Specification
Laser medium	GaAlAs semiconductor
Wavelength	650 nm
Laser probes	11 laser beams + 2 nasal cavity beams
Output power per diode	2–5 mW
Operating voltage	3.0 V
Input voltage	100–240 V
Timer range	10–60 mins (adjustable)
Operating temperature	-20°C to 40°C
Humidity	≤85%
Atmospheric pressure	86–106 kPa
Battery	1800 mAh lithium
Packaging	1 pc/box (19×12×13 cm)

What are the COZING-WS11-NOSE clinical results?

After 30 minutes (microscopic observation):

Red blood cells become activated and dispersed.

After 1–3 months:

Symptoms like headache, dizziness, chest tightness, shortness of breath, palpitations, drowsiness, insomnia, numbness, and memory loss improve or disappear.

After 3 months:

Blood tests show normalized levels of blood viscosity, cholesterol, triglycerides, and LDL.

After 6+ months (long-term use):

Effectively improves Type 2 diabetes by balancing pancreatic function.

Reduces risks of cardiovascular disease, stroke, sudden death, and hemiplegia.